Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
124,058,172
-
Total 13F shares
-
38,834,584
-
Share change
-
+2,203,827
-
Total reported value
-
$149,117,927
-
Put/Call ratio
-
145%
-
Price per share
-
$3.84
-
Number of holders
-
59
-
Value change
-
+$3,712,534
-
Number of buys
-
33
-
Number of sells
-
32
Institutional Holders of ADC Therapeutics SA - Common Shares (ADCT) as of Q4 2022
As of 31 Dec 2022 ADC Therapeutics SA - Common Shares (ADCT) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,834,584 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, FMR LLC, MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 59 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.